ONCOINVENT ASA logo ONCOINVENT ASA

Selskapsinformasjon

Ticker: ONCIN
Børsverdi: 339 MNOK
Nordnet 3 434
Avanza 52
Kommende hendelserHendelser ℹ️
Rapport: 27.08.2026
18.06.2026 07:00

Oncoinvent achieves 50% recruitment milestone in Phase 2 ovarian cancer study of Radspherin[®]

· Strong recruitment momentum demonstrated in 2026 · Year-to-date recruitment has already surpassed total enrollment for 2025 Oslo, Norway, 18 June 2026: Oncoinvent, a clinical-stage radiopharmaceutical company developing Radspherin[®], a receptor-independent alpha-emitting therapy to eradicate ca...

Les hele pressemeldingen

Antall Eiere